Press releases
- BioVaxys Technology Corp. Announces Failure to File Cease Trade Order
- Canadian Investment Regulatory Organization Trading Halt - BIOV
- BioVaxys Technology Corp. Closes SECOND Tranche of Private Placement
- BioVaxys Technology Corp. Closes First Tranche of Private Placement
- BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
- BIOVAXYS APPOINTS CHRISTOPHER CHERRY AS CHIEF FINANCIAL OFFICER
- BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF FIELD TRIAL FOR LARGE-SCALE IMMUNOCONTRACEPTION IN THE COMMERCIAL AQUATIC FARMING INDUSTRY
More ▼
Key statistics
As of last trade Biovaxys Technology Corp (5LB:FRA) traded at 0.0365, -49.02% below its 52-week high of 0.0716, set on Feb 13, 2024.
52-week range
Open | 0.00 |
---|---|
High | 0.00 |
Low | 0.00 |
Bid | -- |
Offer | -- |
Previous close | 0.0365 |
Average volume | -- |
---|---|
Shares outstanding | 220.24m |
Free float | 206.31m |
P/E (TTM) | -- |
Market cap | 15.42m CAD |
EPS (TTM) | -0.1112 CAD |
Data delayed at least 15 minutes, as of May 17 2024 07:01 BST.
More ▼